HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Naucler, P. Articles by Dillner, J. Search for Related Content PubMed PubMed Citation Articles by Naucler, P. Articles by Dillner, J. Agricola Articles by Naucler, P. Articles by Dillner, J.

Human papillomavirus genotypes in cervical cancers in Mozambique

¹ Department of Medical Microbiology, University of Lund, S-20502 Malmö, Sweden
² Department of Gynaecology and Obstetrics, Central Hospital of Maputo, Mozambique
³ Department of Pathology, Malmö University Hospital, Sweden

Correspondence
Joakim Dillner
joakim.dillner{at}mikrobiol.mas.lu.se

The distribution of human papillomavirus (HPV) types in cervical cancers is essential for design and evaluation of HPV type-specific vaccines. To follow up on a previous report that HPV types 35 and 58 were the dominant HPV types in cervical neoplasia in Mozambique, the HPV types in a consecutive case series of 74 invasive cervical cancers in Mozambique were determined. The most common worldwide major oncogenic HPV types 16 and 18 were present in 69 % of cervical cancers, suggesting that a vaccine targeting HPV-16 and -18 would have a substantial impact on cervical cancer also in Mozambique.

This article has been cited by other articles:

				B. Allan, D. J. Marais, M. Hoffman, S. Shapiro, and A.-L. Williamson Cervical Human Papillomavirus (HPV) Infection in South African Women: Implications for HPV Screening and Vaccine Strategies J. Clin. Microbiol., February 1, 2008; 46(2): 740 - 742. [Abstract] [Full Text] [PDF]

				P. Naucler, H.-C. Chen, K. Persson, S.-L. You, C.-Y. Hsieh, C.-A. Sun, J. Dillner, and C.-J. Chen Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study J. Gen. Virol., March 1, 2007; 88(3): 814 - 822. [Abstract] [Full Text] [PDF]

				S. Franceschi and G. M. Clifford Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests J Natl Cancer Inst, June 15, 2005; 97(12): 938 - 939. [Full Text] [PDF]